Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · IEX Real-Time Price · USD
2.600
+0.020 (0.78%)
At close: Apr 24, 2024, 4:00 PM
2.620
+0.020 (0.77%)
After-hours: Apr 24, 2024, 6:35 PM EDT
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $377.24 million as of April 24, 2024. Its market cap has decreased by -67.96% in one year.
Market Cap
377.24M
Enterprise Value
257.34M
1-Year Change
-67.96%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.88B to $377.24M, a decrease of -92.26%. That is a compound annual growth rate of -41.15%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 374.30M | 2.77% |
Apr 22, 2024 | 364.20M | 4.60% |
Apr 19, 2024 | 348.20M | 2.77% |
Apr 18, 2024 | 338.80M | -4.29% |
Apr 17, 2024 | 354.00M | -11.28% |
Apr 16, 2024 | 399.00M | -5.50% |
Apr 15, 2024 | 422.20M | -3.32% |
Apr 12, 2024 | 436.70M | 14.89% |
Apr 11, 2024 | 380.10M | -1.88% |
Apr 10, 2024 | 387.40M | -8.87% |
Apr 9, 2024 | 425.10M | 3.53% |
Apr 8, 2024 | 410.60M | 9.70% |
Apr 5, 2024 | 374.30M | -5.50% |
Apr 4, 2024 | 396.10M | 1.88% |
Apr 3, 2024 | 388.80M | -10.08% |
Apr 2, 2024 | 432.40M | -4.17% |
Apr 1, 2024 | 451.20M | -3.11% |
Mar 28, 2024 | 465.70M | 11.07% |
Mar 27, 2024 | 419.30M | 0.34% |
Mar 26, 2024 | 417.90M | -7.69% |
Mar 25, 2024 | 452.70M | -3.70% |
Mar 22, 2024 | 470.10M | -2.71% |
Mar 21, 2024 | 483.20M | -1.47% |
Mar 20, 2024 | 490.40M | 3.35% |
Mar 19, 2024 | 474.50M | 2.84% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cibus | 359.57M |
Aura Biosciences | 355.94M |
Rani Therapeutics Holdings | 354.61M |
Amarin Corporation | 351.30M |
Alto Neuroscience | 348.42M |
Caribou Biosciences | 347.71M |
Tactile Systems Technology | 342.14M |
PepGen | 341.22M |